Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

660

Participants

Timeline

Start Date

June 29, 2020

Primary Completion Date

May 30, 2022

Study Completion Date

June 18, 2024

Conditions
Diabetic Macular EdemaType 1 Diabetes MellitusType 2 Diabetes Mellitus
Interventions
DRUG

aflibercept

Intravitreally (IVT) administered as a liquid formulation in a vial

DRUG

High-dose aflibercept

Intravitreally (IVT) administered as a liquid formulation in a vial

Trial Locations (138)

11021

Regeneron Study Site, Great Neck

11221

Regeneron Study Site, New York

11572

Regeneron Study Site, Oceanside

13088

Regeneron Study Site, Liverpool

15146

Regeneron Study Site, Monroeville

17036

Regeneron Study Site, Neubrandenburg

18017

Regeneron Study Site, Bethlehem

18704

Regeneron Study Site, Kingston

21209

Regeneron Study Site, Baltimore

21740

Regeneron Study Site, Hagerstown

22031

Regeneron Study Site, Fairfax

23502

Regeneron Study Site, Norfolk

26506

Regeneron Study Site, Morgantown

28210

Regeneron Study Site, Charlotte

28803

Regeneron Study Site, Asheville

29169

Regeneron Study Site, West Columbia

29456

Regeneron Study Site, Ladson

29902

Regeneron Study Site, Beaufort

30060

Regeneron Study Site 1, Marietta

Regeneron Study Site 2, Marietta

30909

Regeneron Study Site, Augusta

32216

Regeneron Study Site, Jacksonville

32806

Regeneron Study Site, Orlando

32901

Regeneron Study Site, Melbourne

33126

Regeneron Study Site, Miami

33308

Regeneron Study Site, Fort Lauderdale

33324

Regeneron Study Site, Plantation

33711

Regeneron Study Site, St. Petersburg

33761

Regeneron Study Site, Clearwater

33770

Regeneron Study Site, Largo

33782

Regeneron Study Site, Pinellas Park

33805

Regeneron Study Site, Lakeland

33880

Regeneron Study Site, Winter Haven

33912

Regeneron Study Site, Fort Myers

34994

Regeneron Study Site, Stuart

37075

Regeneron Study Site, Göttingen

37203

Regeneron Study Site, Nashville

37922

Regeneron Study Site, Knoxville

38138

Regeneron Study Site, Germantown

38671

Regeneron Study Site, Southaven

43016

Regeneron Study Site, Dublin

44122

Regeneron Study Site, Beachwood

44130

Regeneron Study Site, Cleveland

45202

Regeneron Study Site, Cincinnati

45242

Regeneron Study Site, Cincinnati

46290

Regeneron Study Site, Carmel

48073

Regeneron Study Site, Royal Oak

48145

Regeneron Study Site, Münster

57701

Regeneron Study Site, Rapid City

60452

Regeneron Study Site, Oak Forest

62703

Regeneron Study Site, Springfield

62704

Regeneron Study Site, Springfield

66204

Regeneron Study Site, Shawnee Mission

73013

Regeneron Study Site, Edmond

74114

Regeneron Study Site, Tulsa

76087

Regeneron Study Site, Willow Park

77384

Regeneron Study Site, The Woodlands

77401

Regeneron Study Site, Bellaire

78240

Regeneron Study Site 2, San Antonio

79606

Regeneron Study Site, Abilene

80228

Regeneron Study Site, Lakewood

80909

Regeneron Study Site, Colorado Springs

81301

Regeneron Study Site, Durango

84107

Regeneron Study Site 1, Salt Lake City

85021

Regeneron Study Site, Phoenix

89052

Regeneron Study Site, Henderson

90211

Regeneron Study Site, Beverly Hills

90509

Regeneron Study Site, Torrance

90807

Regeneron Study Site, Long Beach

91006

Regeneron Study Site, Arcadia

91107

Regeneron Study Site, Pasadena

91436

Regeneron Study Site, Encino

92064

Regeneron Study Site, Poway

92505

Regeneron Study Site, Riverside

92647

Regeneron Study Site, Huntington Beach

92835

Regeneron Study Site, Fullerton

94303

Regeneron Study Site, Palo Alto

95008

Regeneron Study Site, Campbell

95670

Regeneron Study Site, Rancho Cordova

96701

Regeneron Study Site, ‘Aiea

97225

Regeneron Study Site, Portland

06385

Regeneron Study Site, Waterford

02114

Regeneron Study Site, Boston

Regeneron Study Site, Shirley

07003

Regeneron Study Site, Bloomfield

08820

Regeneron Study Site, Edison

07666

Regeneron Study Site, Teaneck

T2H 0C8

Regeneron Study Site, Calgary

L4W 1W9

Regeneron Study Site, Mississauga

M3C 0G9

Regeneron Study Site, North York

J1G 2V4

Regeneron Study Site, Sherbrooke

530 02

Regeneron Study Site, Pardubice

100 34

Regeneron Study Site, Prague

128 08

Regeneron Study Site, Prague

150 00

Regeneron Study Site, Prague

H-7621

Regeneron Study Site 1, Pécs

H-9700

Regeneron Study Site, Szombathely

H-8900

Regeneron Study Site, Zalaegerszeg

H-1085

Regeneron Study Site, Budapest

H-1106

Regeneron Study Site, Budapest

H-1133

Regeneron Study Site, Budapest

H-1145

Regeneron Study Site, Budapest

H-4032

Regeneron Study Site, Debrecen

H-6720

Regeneron Study Site, Szeged

480-1195

Regeneron Study Site, Nagakute

466-8560

Regeneron Study Site, Nagoya

467-8602

Regeneron Study Site, Nagoya

910-1193

Regeneron Study Site, Yoshida-Gun

830-0011

Regeneron Study Site, Kurume

963-8052

Regeneron Study Site, Kōriyama

041-0851

Regeneron Study Site, Hakodate

650-0017

Regeneron Study Site, Kobe

310-0845

Regeneron Study Site, Mito

302-0014

Regeneron Study Site, Toride

300-0817

Regeneron Study Site, Tsuchiura-shi

761-0793

Regeneron Study Site, Kita-gun

216-8511

Regeneron Study Site, Kawasaki

390-8621

Regeneron Study Site, Matsumoto

852-8501

Regeneron Study Site, Nagasaki

634-8522

Regeneron Study Site, Kashihara

573-1191

Regeneron Study Site, Hirakata

359-8513

Regeneron Study Site, Tokorozawa

410-1102

Regeneron Study Site, Susono

329-0498

Regeneron Study Site, Shimotsuke-shi

101-8309

Regeneron Study Site, Chiyoda-ku

193-0998

Regeneron Study Site, Hachiōji

173-0015

Regeneron Study Site, Itabashi-ku

152-8902

Regeneron Study Site, Meguro-ku

755-8505

Regeneron Study Site, Ube

812-0011

Regeneron Study Site, Fukuoka

819-8585

Regeneron Study Site, Fukuoka

890-8520

Regeneron Study Site, Kagoshima

545-8586

Regeneron Study Site, Osaka

330-8553

Regeneron Study Site, Saitama

770-8503

Regeneron Study Site, Tokushima

00612

Regeneron Study Site, Arecibo

SR2 9HP

Regeneron Study Site, Sunderland

EC1V 2PD

Regeneron Study Site, London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Regeneron Pharmaceuticals

INDUSTRY

NCT04429503 - Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease | Biotech Hunter | Biotech Hunter